Table 1 Clinical, demographic, parasitological and drug susceptibility data for all strains
Strain | Amphotericin B (μg/mL) | Fluconazole (μg/mL) | Isolate Origin | New or Old World Origin | Clinical Manifestation |
|---|---|---|---|---|---|
L. amazonensis ATCC®50159™ | 0.58 ± 0.22 | ≥256 | Brazil | New World | CL |
L. chagasi ATCC®50133™ | 0.33 ± 0.08 | ≥256 | Brazil | New World | VL |
L. donovani ATCC®50212™ | 0.25 ± 0.00 | ≥256 | India | Old World | VL |
L. infantum ATCC®50134™ | 0.22 ± 0.07 | ≥256 | Tunisia | Old World | VL |
L. major ATCC®50122™ | 0.44 ± 0.06 | ≥256 | Israel | Old World | CL |
L. mexicana ATCC®50157™ | 0.33 ± 0.08 | ≥256 | Belize | New World | CL |
L. tropica ATCC®50129™ | 0.25 ± 0.00 | ≥256 | Former USSR (Azerbaidjanskaya) | Old World | CL |
L. V. braziliensis ATCC® 50135™ | 0.25 ± 0.00 | ≥256 | Brazil | New World | CL or ML |
L. V. guyanensis ATCC®50126™ | 0.39 ± 0.09 | ≥256 | Brazil | New World | CL or ML |
L. V. panamensis ATCC®50158™ | 0.5 ± 0.00 | ≥256 | Panama | New World | CL or ML |
Clinical L. infantum 1 | 0.12 ± 0.00 | ≥256 | Italy | Old World | VL |
Clinical L. tropica 1 | 0.25 ± 0.00 | ≥256 | Afghanistan | Old World | CL |
Clinical L. tropica 2 | 0.25 ± 0.00 | ≥256 | Afghanistan | Old World | CL |
Clinical L. V. braziliensis 1 | 0.5 ± 0.00 | ≥256 | Peru | New World | CL |
Clinical L. V. panamensis 1 | 0.12 ± 0.00 | ≥256 | Costa Rica | New World | CL |
Clinical L. V. panamensis 2 | 0.16 ± 0.04 | ≥256 | Costa Rica | New World | CL |
Clinical L. V. panamensis 3 | 0.12 ± 0.00 | ≥256 | Costa Rica | New World | CL |
Clinical L. V. panamensis 4 | 0.67 ± 0.17 | ≥256 | Ecuador | New World | CL |
Clinical L. V. panamensis 5 | 0.49 ± 0.08 | ≥256 | Costa Rica | New World | CL |